Drugs / Botulinum Type B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01671800 | Sep 2008 → Dec 2012 | — | Henry M. Jackson Foundation for the Advancement of Military Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Botulinum Type B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01671800 ↗ |
| Route | Other | “receive either the drug or placebo by injection into the residual limb area” NCT01671800 ↗ |